Preclinical Reproductive and Developmental Toxicity Profile of a Glycine Transporter Type 1 (Glyt1) Inhibitor.

about

Preclinical Reproductive and Developmental Toxicity Profile of a Glycine Transporter Type 1 (Glyt1) Inhibitor.

Item

http://www.wikidata.org/entity/Q46308311

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Preclinical Reproductive and D ...... rter Type 1 (Glyt1) Inhibitor.

@en

Preclinical Reproductive and D ...... f a Glycine Transporter Type 1

@nl

type

Item

label

Preclinical Reproductive and D ...... rter Type 1 (Glyt1) Inhibitor.

@en

Preclinical Reproductive and D ...... f a Glycine Transporter Type 1

@nl

prefLabel

Preclinical Reproductive and D ...... rter Type 1 (Glyt1) Inhibitor.

@en

Preclinical Reproductive and D ...... f a Glycine Transporter Type 1

@nl

P1476

Preclinical Reproductive and D ...... orter Type 1 (Glyt1) Inhibitor

@en

P2093

Annette Koerner

http://www.w3.org/2001/XMLSchema#string

Axel Paehler

http://www.w3.org/2001/XMLSchema#string

Daniela Alberati

http://www.w3.org/2001/XMLSchema#string

Neil Parrott

http://www.w3.org/2001/XMLSchema#string

P2860

Sodium-coupled neutral amino acid (System N/A) transporters of the SLC38 gene family

D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia

Immunohistochemical localization of the amino acid transporter SNAT2 in the rat brain

Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence

Imaging the glutamate system in humans: relevance to drug discovery for schizophrenia.

Glycine reuptake inhibitor RG1678: a pharmacologic characterization of an investigational agent for the treatment of schizophrenia.

Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism.

Glycine transporters as novel therapeutic targets in schizophrenia, alcohol dependence and pain.

Effect of bitopertin, a glycine reuptake inhibitor, on negative symptoms of schizophrenia: a randomized, double-blind, proof-of-concept study.

A double-blind randomized study assessing safety and efficacy following one-year adjunctive treatment with bitopertin, a glycine reuptake inhibitor, in Japanese patients with schizophrenia.

P304

148-156

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/BDRB.21179

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P50

Paul C Barrow

P577

2016-05-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27221585

http://www.w3.org/2001/XMLSchema#string

P921

maternal health